(Q46068078)

19 December 2017

title

Validation of the archimedes diabetes model (English)

1 reference

19 December 2017

Validation of the Archimedes Diabetes Model (English)

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

modelling biological systems

25 March 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578246

25 March 2024

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

25 March 2024

1

David M Eddy

1 reference

19 December 2017

Leonard Schlessinger

2

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

19 December 2017

full work available at URL

published in

Diabetes Care

1 reference

19 December 2017

volume

26

1 reference

19 December 2017

issue

11

1 reference

19 December 2017

page(s)

3102-3110

1 reference

19 December 2017

Archimedes: a trial-validated model of diabetes

cites work

1

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

25 March 2024

3

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

25 March 2024

4

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

25 March 2024

5

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

25 March 2024

6

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

25 March 2024

7

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

25 March 2024

8

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

25 March 2024

9

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

25 March 2024

10

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

25 March 2024

11

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

25 March 2024

12

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

25 March 2024

13

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

25 March 2024

14

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

25 March 2024

15

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

25 March 2024

16

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

25 March 2024

19

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

25 March 2024

20

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

25 March 2024

21

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Predicting CHD risk in patients with diabetes mellitus

25 March 2024

25

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Coronary heart disease risk assessment in diabetes mellitus--a comparison of PROCAM and Framingham risk assessment functions.

25 March 2024

27

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

The Mt. Hood challenge: cross-testing two diabetes simulation models

25 March 2024

28

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

Archimedes: a new model for simulating health care systems--the mathematical formulation.

25 March 2024

30

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.11.3102

25 March 2024

Identifiers

1 reference

19 December 2017

release_h4yym4hf5retdlspb2o5jcvu7q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h4yym4hf5retdlspb2o5jcvu7q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

19 December 2017